Considering that ACE2 antagonizes the effects of ACE, it is probable that downregulation of ACE2 expression as in SARS-CoV-2 infection (4), which implies elevated ACE activity, may potentiate prostate carcinogenesis. The gene discussed is ACE2; the disease is medical procedure.